Physician profile
Justin David Wright
NPI 1386613909
$10,679.54
in general payments reported to CMS, 2019-2025
54 companies · $880 in 2025
The $880 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2020: $1,428 · 2021: $1,998 · 2022: $1,670 · 2023: $1,867 · 2024: $1,225 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,846 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,846.19 |
| Education | $125.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,691.89 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,001.25 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $911.23 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $800.79 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $711.99 | 2019-2025 | Evenity, Prolia, Otezla |
| Pfizer INC. | $522.21 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $456.35 | 2019-2024 | Breztri, Andexxa |
| Sanofi-Aventis U.S. LLC | $367.46 | 2019-2025 | |
| Glaxosmithkline, LLC. | $337.77 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.52 | 2019-2024 | Synjardy, Jardiance |
| Merck Sharp & Dohme LLC | $334.34 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Allergan, INC. | $296.52 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $286.84 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $246.76 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $200.13 | 2019-2024 | Rexulti |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.